The world is obsessed with vaccines. Well, in truth, it’s those vaccines that will hopefully set us free from COVID and allow us to return to something close to call normal life.
The link between fighting COVID and cancer
At the time of writing, at least 150 million vaccine doses have been administered in the US, and I have received both my Pfizer shots. The Pfizer vaccine was developed in conjunction with the German company BioNTech. BioNTech, a relatively small firm, needed the muscle of pharma giant Pfizer to help run large clinical trials and scale up mass production to meet global demand.
Prior to turning their attention to coronavirus, BioNTech had been working on finding ways to help the immune system tackle cancer. Following the success of their COVID vaccine, the value and profile of the company has grown, increasing its potential ability to have access to resources that will help in their continuing fight against cancer.
Exploring the connection
Interestingly, there is direct cross-over in the research required to beat coronavirus and cancer. In many instances, both use mRNA-based vaccines that enable the immune system to attack a predatory intruder.
The Unwelcome Guest 